Perceptive Advisors

Perceptive Advisors puts capital into biotechnology and other healthcare businesses. The firm began in 1999 and staffs its team with scientists, doctors and technologists who assess whether a new therapy or device is likely to work.

Services

• Private company investment: financing for young life sciences firms developing therapies and devices.
• Public company investment: positions across the capital structure of listed healthcare companies.
• Multiple strategies: several investment approaches so it can back a company at different points in its growth.
• Scientific review: evaluation of efficacy and impact from technical, scientific and financial viewpoints.

Who it works with

It backs companies in gene therapy, cancer immunotherapy, medical devices, specialty pharmaceuticals and diabetes care. Named portfolio examples include 4D Molecular Therapeutics, Achilles Therapeutics, Agile Therapeutics, Aquestive and Athenex.

Key facts

• Founded: 1999
• Team: molecular biologists, MDs, PhDs and technologists
• Sector: life sciences and healthcare